SLT Holdings »

Leap Therapeutics shares owned by SLT Holdings

Quarter-by-quarter ownership of Leap Therapeutics (CYPH) shares owned by SLT Holdings from 13F filings

Historical chart of SLT Holdings investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by SLT Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by SLT Holdings

Quarter filed Position value Share count Share price at filing
2026-09-30 $1.2M 346k 3.33

More positions owned by SLT Holdings

NVIDIA Corporation (NVDA)
Apple (AAPL)
Grayscale Bitcoin Trust Etf Shs Rep Com Ut (GBTC)
Microsoft Corporation (MSFT)
Spdr Series Trust St Str Blo 1 Etf (BIL)
Amazon (AMZN)
Broadcom (AVGO)
Crowdstrike Hldgs Cl A (CRWD)
Asml Hldg Nv N Y Registry Shs (ASML)
D-wave Quantum (QBTS)
First Tr Exchng Traded Fd Vi Ft Ladd Buff Etf (BUFR)
UnitedHealth (UNH)
Clearway Energy CL C Call Option (CWEN)
Alphabet Cap Stk Cl C (GOOG)
Advanced Micro Devices (AMD)

View all positions for SLT Holdings

Top funds holding Leap Therapeutics

Vanguard Capital Management
BlackRock
Jane Street
Citadel Advisors
Geode Capital Management
UBS Group
Susquehanna International
XTX Topco
Vanguard Fiduciary Trust
State Street Corporation
SLT Holdings
Cygnus Capital Advisors
Northern Trust
LPL Financial
Sequoia Financial Advisors

View all funds holding Leap Therapeutics